Monoclonal antibody to β peptide, recognizing amyloid deposits, neuronal cells and lipofuscin pigments in systemic organs

[1]  K. Wisniewski,et al.  Altered amyloid β-protein precursor processing in brains of patients with neuronal ceroid lipofuscinosis , 1990, Neuroscience Letters.

[2]  P. Cras,et al.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. , 1990, The American journal of pathology.

[3]  K. Beyreuther,et al.  Ultrastructural localization of the putative precursors of the A4 amyloid protein associated with Alzheimer's disease. , 1990, The American journal of pathology.

[4]  T. Wisniewski,et al.  β-Protein immunoreactivity in brains of patients with neuronal ceroid lipofuscinosis: Ultrastructural and biochemical demonstration , 1990, Neuroscience Letters.

[5]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[6]  R. Neve,et al.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.

[7]  D. Selkoe,et al.  Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.

[8]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[9]  E. Schon,et al.  Widespread expression of amyloid beta-protein precursor gene in rat brain. , 1989, The American journal of pathology.

[10]  J. Trojanowski,et al.  Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. , 1989, The American journal of pathology.

[11]  H. Wiśniewski,et al.  Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Wiśniewski,et al.  Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein , 1989, Neurobiology of Aging.

[13]  K. Ogomori,et al.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. , 1989, The American journal of pathology.

[14]  L. G. Davis,et al.  Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system , 1988, Neuron.

[15]  D. Selkoe,et al.  Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques. , 1988, Biochemical and biophysical research communications.

[16]  D. Selkoe,et al.  Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.

[18]  G. Glenner,et al.  Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Morrison,et al.  Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Younkin,et al.  In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Morrison,et al.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. , 1987, Science.

[22]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[24]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[25]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[26]  D. Palmer,et al.  Ceroid lipofuscinosis in sheep. II. The major component of the lipopigment in liver, kidney, pancreas, and brain is low molecular weight protein. , 1986, The Journal of biological chemistry.

[27]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[28]  C. Masters,et al.  AMYLOID PLAQUE CORE PROTEIN IN ALZHEIMERʼS DISEASE AND AGED DOWNʼS SYNDROME , 1985 .

[29]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[30]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[31]  H. Hatanaka,et al.  Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line , 1981, Brain Research.

[32]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Hirokawa,et al.  Establishment of a monoclonal antibody against senile plaques and its application for immunohistological and immunoelectron microscopical studies in the brain of the elderly , 2004, Acta Neuropathologica.

[34]  S. Hirai,et al.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia , 1988, Acta Neuropathologica.

[35]  S. Hirai,et al.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining , 2004, Acta Neuropathologica.

[36]  H. Goebel,et al.  Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein , 2004, Acta Neuropathologica.

[37]  K. Hirokawa,et al.  Immunohistological study of senile brains by using a monoclonal antibody recognizing β amyloid precursor protein: significance of granular deposits in relation with senile plaques , 2004, Acta Neuropathologica.

[38]  G. Glenner,et al.  Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[39]  C. Marotta,et al.  Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Selkoe,et al.  Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. , 1989, Nature.

[41]  S. Younkin,et al.  In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimerʼs disease , 1988 .

[42]  R. Tanzi,et al.  Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus , 1988 .

[43]  K. Hirokawa,et al.  Analysis of the thymic microenvironment by monoclonal antibodies with special reference to thymic nurse cells. , 1986, Thymus.

[44]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.